source
- Caspian Therapeutics launches with $50M funding and Eli Lilly backing to develop menin inhibitor for diabetesCaspian Therapeutics has been created as a spin-out from Kura Oncology to advance a menin-targeting drug for diabetes. The company received $50 million in initial capital, led by BVF Partners with…
- AMA chief says AI will augment, not replace, physiciansJohn Whyte, the chief executive of the American Medical Association, wrote an opinion piece asserting that artificial intelligence should work alongside doctors rather than take their place. He po…